(Q51581141)

7 April 2018

title

Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. (English)

1 reference

7 April 2018

1 reference

6

B Persson

1 reference

7 April 2018

S Kumar

1

1 reference

7 April 2018

A J Boulton

2

1 reference

7 April 2018

H Beck-Nielsen

3

1 reference

7 April 2018

F Berthezene

4

1 reference

7 April 2018

M Muggeo

5

1 reference

7 April 2018

G A Spinas

7

1 reference

7 April 2018

S Donoghue

8

1 reference

7 April 2018

S Lettis

9

1 reference

7 April 2018

P Stewart-Long

10

1 reference

7 April 2018

publication date

1 June 1996

1 reference

7 April 2018

published in

Diabetologia

1 reference

7 April 2018

volume

39

1 reference

7 April 2018

issue

6

1 reference

7 April 2018

page(s)

701-709

1 reference

7 April 2018

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

cites work

1 reference

12 December 2020

Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes.

1 reference

12 December 2020

The fourth musketeer--from Alexandre Dumas to Claude Bernard

1 reference

12 December 2020

Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study

1 reference

12 December 2020

Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study.

1 reference

12 December 2020

Oral hypoglycemic agents

1 reference

12 December 2020

United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years

1 reference

12 December 2020

Pathogenesis of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study

1 reference

12 December 2020

Can Life-styles of Subjects With Impaired Glucose Tolerance Be Changed? A Feasibility Study

1 reference

12 December 2020

Management of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

12 December 2020

Radioimmunological determination of human C-peptide in serum

1 reference

12 December 2020

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

1 reference

12 December 2020

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

1 reference

12 December 2020

A pilot clinical trial of a new oral hypoglycemic agent, CS-045, in patients with non-insulin dependent diabetes mellitus.

1 reference

12 December 2020

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

12 December 2020

Effects of a new oral hypoglycaemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes.

1 reference

12 December 2020

Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment.

1 reference

12 December 2020

Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats

1 reference

12 December 2020

Critical Variables in the Radioimmunoassay of Serum Insulin Using the Double Antibody Technic

1 reference

12 December 2020

Suppression of non-esterified fatty acids to treat type A insulin resistance syndrome.

1 reference

12 December 2020

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

1 reference

12 December 2020

Pathogenesis of NIDDM. A balanced overview

1 reference

12 December 2020

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

12 December 2020

Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts

1 reference

12 December 2020

Studies on hindered phenols and analogues. V. Synthesis, identification, and antidiabetic activity of the glucuronide of CS-045

1 reference

12 December 2020

Mechanisms decreasing glucose oxidation in diabetes and starvation: role of lipid fuels and hormones.

1 reference

12 December 2020

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

12 December 2020

Identifiers

DOI

10.1007/S001250050498

1 reference

7 April 2018

1 reference

7 April 2018